Zhu J - Search Results

1

Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis.

Song Y, Zhou K, Zou D, Li D, Hu J, Yang H, Zhang H, Ji J, Xu W, Jin J, Lv F, Feng R, Gao S, Zhou D, Tam CS, Simpson D, Wang M, Phillips TJ, Opat S, Fang C, Sun S, Zhu J. Song Y, et al. Among authors: zhu j. Cancer Med. 2023 Sep;12(18):18643-18653. doi: 10.1002/cam4.6473. Epub 2023 Sep 14. Cancer Med. 2023. PMID: 37705497 Free PMC article.

2

Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades.

Liu W, Ji X, Song Y, Wang X, Zheng W, Lin N, Tu M, Xie Y, Ping L, Ying Z, Zhang C, Deng L, Wu M, Feng F, Leng X, Sun Y, Du T, Zhu J. Liu W, et al. Among authors: zhu j. Cancer Med. 2020 Jun;9(11):3765-3774. doi: 10.1002/cam4.3037. Epub 2020 Apr 12. Cancer Med. 2020. PMID: 32281275 Free PMC article.

3

Autologous hematopoietic stem cell transplantation with inadequate stem cell dose in patients with non-Hodgkin lymphoma.

Liu W, Wu M, Xie Y, Zhang C, Ping L, Feng F, Leng X, Mi L, Wang X, Zhu J, Song Y. Liu W, et al. Among authors: zhu j. Leuk Lymphoma. 2021 Feb;62(2):323-329. doi: 10.1080/10428194.2020.1834092. Epub 2020 Oct 15. Leuk Lymphoma. 2021. PMID: 33054458

4

Germline variants of DNA repair genes in early onset mantle cell lymphoma.

Wang X, Song Y, Chen W, Ding N, Liu W, Xie Y, Wang Y, Zhu J, Zeng C. Wang X, et al. Among authors: zhu j. Oncogene. 2021 Jan;40(3):551-563. doi: 10.1038/s41388-020-01542-2. Epub 2020 Nov 15. Oncogene. 2021. PMID: 33191405

5

Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in China.

Ying Z, Yang H, Guo Y, Li W, Zou D, Zhou D, Wang Z, Zhang M, Wu J, Liu H, Zhang P, Yang S, Zhou Z, Zheng H, Song Y, Zhu J. Ying Z, et al. Among authors: zhu j. Cancer Med. 2021 Feb;10(3):999-1011. doi: 10.1002/cam4.3686. Epub 2020 Dec 31. Cancer Med. 2021. PMID: 33382529 Free PMC article. Clinical Trial.

6

Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: Extended follow-up of the multicenter, single-arm, Phase 2 study.

Wu J, Song Y, Chen X, Lin T, Cao J, Liu Y, Zhao Y, Jin J, Huang H, Hu J, Luo J, Zhang L, Xue H, Zhang Q, Wang W, Chen C, Feng J, Zhu J. Wu J, et al. Among authors: zhu j. Int J Cancer. 2022 Mar 15;150(6):984-992. doi: 10.1002/ijc.33852. Epub 2021 Nov 5. Int J Cancer. 2022. PMID: 34674396 Clinical Trial.

7

Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study.

Song Y, Zhou K, Zou D, Zhou J, Hu J, Yang H, Zhang H, Ji J, Xu W, Jin J, Lv F, Feng R, Gao S, Guo H, Zhou L, Huang J, Novotny W, Kim P, Yu Y, Wu B, Zhu J. Song Y, et al. Among authors: zhu j. Blood. 2022 May 26;139(21):3148-3158. doi: 10.1182/blood.2021014162. Blood. 2022. PMID: 35303070 Free PMC article. Clinical Trial.

8

A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma.

Liu W, Ping L, Xie Y, Sun Y, Du T, Niu Y, Cisternas G, Huang F, Garcia-Vargas J, Childs BH, Mehra A, Reschke S, Wang X, Song Y, Zhu J. Liu W, et al. Among authors: zhu j. Cancer Chemother Pharmacol. 2022 Jun;89(6):825-831. doi: 10.1007/s00280-022-04417-3. Epub 2022 Mar 23. Cancer Chemother Pharmacol. 2022. PMID: 35322287 Clinical Trial.

9

A two-part, single-arm, multicentre, phase I study of zanubrutinib, a selective Bruton tyrosine kinase inhibitor, in Chinese patients with relapsed/refractory B-cell malignancies.

Song Y, Sun M, Qi J, Xu W, Zhou J, Li D, Li J, Qiu L, Du C, Guo H, Huang J, Tang Z, Ou Y, Wu B, Yu Y, Zhu J. Song Y, et al. Among authors: zhu j. Br J Haematol. 2022 Jul;198(1):62-72. doi: 10.1111/bjh.18162. Epub 2022 Apr 5. Br J Haematol. 2022. PMID: 35383885 Free PMC article. Clinical Trial.

10

Preliminary efficacy and safety of Relmacabtagene autoleucel (Carteyva) in adults with relapsed/refractory follicular lymphoma in China: A phase I/II clinical trial.

Ying Z, Zou D, Yang H, Wu J, Guo Y, Li W, Liu H, Wang C, Ma L, Yang S, Zhou Z, Qin Y, Song Y, Zhu J. Ying Z, et al. Among authors: zhu j. Am J Hematol. 2022 Dec;97(12):E436-E438. doi: 10.1002/ajh.26711. Epub 2022 Sep 14. Am J Hematol. 2022. PMID: 36053875 Free article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,941 results

Search Page

Filters